0001562180-22-003585.txt : 20220429 0001562180-22-003585.hdr.sgml : 20220429 20220429210019 ACCESSION NUMBER: 0001562180-22-003585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220428 FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUGIN ROBERT J CENTRAL INDEX KEY: 0001232505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 22878766 MAIL ADDRESS: STREET 1: C/O THE MEDICINES CO STREET 2: 8 CAMPUS DR CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-04-28 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001232505 HUGIN ROBERT J C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 true false false false Stock Option (Right to Buy) 97.74 2022-04-28 4 A false 8239.00 0.00 A 2032-04-27 Common Shares 8239.00 8239.00 D The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. /s/ George Clark, Attorney-in-Fact 2022-04-29